241-250 of 320 results
Full Federal Court overturns decision allowing patent term extension of 'Swiss-style' claims
The Full Federal Court has unanimously held that patent term extensions are not available for second medical use claims involving the use of recombinant DNA technology This decision overturns a controversial finding of the Administrative Appeals Tribunal last year and means that any patent term ...
Patent examination guidelines in the wake of Myriad
Following public consultation on proposed examination guidelines issued on 16 October 2015 the Commissioner of Patents has established a revised examination practice taking into account the High Courts decision in emDArcy v Myriad Genetics Incem Dr Trevor Davies Partner at Allens Patent amp Trade ...
Direct .au registrations, a new internet tax or a way to strengthen the .au market?
In the most significant change since the .au domain was introduced more than 30 years ago, .au Domains Administration (auDA), the industry body for Australian-specific domain names, has approved the registration of .au second-level domain names, known as direct registration. ...
ICANN caught in regulatory web
Since it took effect in May 2018 across the entire European Union, the General Data Protection Regulation has sent shockwaves through countless internet infrastructure industries ...
Second round of changes to Australia's IP laws released for comment
IP Australia has released draft legislation to implement the second part of the Government's response to the Productivity Commission's inquiry into IP arrangements. Senior Associate Lauren John reports. ...
US Postal Service breaches copyright in the Statue of Las Vegas
In this issue we look at challenges for domain name searching posed by the GDPR the second round of draft amendments to the Patents Act developments in the patentability of computer-implemented inventions the dangers of falsely marking products as patented the latest brand wars in the Federal Court ...
Review your IP arrangements: IP exemption from competition laws soon to be repealed
Section 51(3) of the Competition and Consumer Act 2010 (CCA), which currently exempts conditional licensing or assignment of IP rights from most of the prohibitions on anti-competitive conduct in the CCA, will be repealed. ...
Faster TGA disclosure - what it means for pharmaceutical patent litigation
The TGA has consulted on whether it should disclose earlier that a prescription medicine is under evaluation and what types of prescription medicines should be published. ...
What do the Swiss and artificial sweetener have to do with patents?
The recent Federal Court decision in Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd [2019] FCA 28 deals with fascinating issues for patentees seeking to enforce Swiss-style claims against makers of bioequivalent products. ...
Major new proposals for regulating personalised medical devices
Proposed amendments to the regulation of personalised medical devices, which introduce a set of new internationally haromised definitions will have a significant impact on the industry ...